PaySign’s Strong Financial Performance and Growth Potential Justify Buy Rating
I'm PortAI, I can summarize articles.
Maxim Group analyst Michael Diana reiterated a Buy rating on PaySign, setting a price target of $8.50, citing strong financial performance and growth potential. PaySign's Q3 results exceeded expectations, driven by new plasma centers and pharma programs. The company raised its 2025 guidance, has no debt, and positive cash flow. D.A. Davidson also maintained a Buy rating with a $9.00 target. Diana's average return is 0.0% with a 50.80% success rate on stocks.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments